ArticleFrontiers in public health2025
Does the trade of medical products contribute to promoting human development?-An empirical analysis based on data from China and RCEP countries.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As the RCEP (Regional Comprehensive Economic Partnership) Agreement deepens, the role of medical product trade in safeguarding regional public health security and promoting economic development has become increasingly prominent. Methods: Based on data from 2004 to 2023, this study employs the stochastic frontier gravity model and benchmark regression model to explore the impact of China's medical product export efficiency on the development indices of RCEP countries. Results: The findings are as follows: (1) China's medical product exports to RCEP countries exhibit simultaneous scale expansion, structural differentiation, and market concentration, with ASEAN, Japan, and South Korea as core markets and mid-to-low-end products dominating the export structure; (2) Trade efficiency evolution reflects dual mechanisms of institutional environment and technological capabilities, where governance levels and health system soundness optimize efficiency, while excessive liberalization and tax burdens increase friction costs; (3) Enhanced export efficiency indirectly promotes human development in RCEP countries by strengthening basic health service coverage, forming a "trade-health-development" transmission mechanism. Conclusion: To enhance export efficiency and achieve synergistic development, we propose: (1) For policymakers: Deepen institutional coordination and establish a "trade-health" collaborative governance framework to amplify public health dividends; (2) For exporters: Implement a tiered market strategy and strengthen technological innovation to enhance industrial resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.